Docoh
Loading...

EMN Eastman Chemical

Filed: 13 May 20, 11:36am

emn-20200507_g1.jpg

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported):
May 7, 2020

EASTMAN CHEMICAL COMPANY
(Exact Name of Registrant as Specified in Its Charter)

Delaware 1-12626 62-1539359
(State or Other Jurisdiction
of Incorporation)
 (Commission File Number) (IRS Employer
Identification No.)

200 South Wilcox Drive 
KingsportTennessee37662
(Address of Principal Executive Offices)(Zip Code)
(423) 229-2000
(Registrant’s Telephone Number, Including Area Code)
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per share EMNNew York Stock Exchange
1.50% Notes Due 2023EMN23New York Stock Exchange
1.875% Notes Due 2026EMN26New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.07 Submission of Matters to a Vote of Security Holders

The 2020 Annual Meeting of the Stockholders of Eastman Chemical Company (the "Company") was held virtually by webcast on May 7, 2020. There were 135,894,258 shares of common stock outstanding and entitled to be voted, and of those shares 115,536,131 (85.02% of the outstanding shares) were represented virtually or by proxy, at the Annual Meeting.

Four items of business were considered by stockholders at the Annual Meeting:
election of ten directors to serve until the Annual Meeting of Stockholders in 2021 and until their successors are duly elected and qualified;
advisory vote on executive compensation as disclosed in the Annual Meeting proxy statement (the “say-on-pay” vote);
ratification of the action by the Audit Committee of the Board of Directors appointing PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2020; and
adoption of an advisory stockholder proposal requesting that the Board of Directors take steps necessary to permit stockholders to act by written consent without a meeting.

The results of the voting on the election of directors were as follows:

Nominee
Votes For
(% of voted shares)
Votes Against
(% of voted shares)
Abstentions
(% of outstanding shares)
Broker Non-Votes
(% of outstanding shares)
Humberto P. Alfonso101,273,151
(98.32%)
1,735,996
(1.68%)
156,903
(0.12%)
12,370,081
(9.10%)
Brett D. Begemann
100,815,697
(97.88%)
2,181,251
(2.12%)
169,100
(0.12%)
12,370,083
(9.10%)
Mark J. Costa
97,074,470
(94.56%)
5,585,576
(5.44%)
506,004
(0.38%)
12,370,081
(9.10%)
Edward L. Doheny II
102,136,530
(99.16%)
864,497
(0.84%)
165,024
(0.12%)
12,370,080
(9.10%)
Julie F. Holder
101,048,456
(98.11%)
1,951,823
(1.89%)
165,768
(0.12%)
12,370,084
(9.10%)
Renée J. Hornbaker
99,055,390
(96.19%)
3,927,604
(3.81%)
183,053
(0.14%)
12,370,084
(9.10%)
Kim Ann Mink
101,623,312
(98.75%)
1,285,272
(1.25%)
257,465
(0.19%)
12,370,082
(9.10%)
James J. O’Brien
101,702,074
(98.74%)
1,303,021
(1.26%)
160,954
(0.12%)
12,370,082
(9.10%)
David W. Raisbeck
97,287,073
(94.48%)
5,682,654
(5.52%)
196,318
(0.15%)
12,370,086
(9.10%)
Charles K. Stevens III
101,825,383
(98.86%)
1,178,130
(1.14%)
162,535
(0.12%)
12,370,083
(9.10%)

Accordingly, each of the ten nominees received a majority of votes cast in favor of that director's election and was elected.















The results of the voting on the advisory "say-on-pay" vote were as follows:
Votes For
(% of voted shares)
Votes Against
(% of voted shares)
Abstentions
(% of outstanding shares)
Broker
Non-Votes
(% of outstanding shares)
80,290,338
(78.10%)
22,513,968
(21.90%)
361,729
(0.27%)
12,370,096
(9.10%)

Accordingly, a majority of votes cast in the advisory "say-on-pay" vote were "for" approval of the executive compensation as disclosed in the Annual Meeting proxy statement.

The results of the voting on the ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for 2020 were as follows:
Votes For
(% of voted shares)
Votes Against
(% of voted shares)
Abstentions
(% of outstanding shares)
Broker
Non-Votes
107,188,648
(92.91%)
8,179,760
(7.09%)
167,723
(0.12%)
Inapplicable

Accordingly, a majority of votes cast on the ratification of the appointment of the independent registered public accounting firm were in favor of the proposal and the appointment of PricewaterhouseCoopers LLP was ratified.

The results of the voting on the advisory stockholder proposal requesting that the Board of Directors take steps necessary to permit stockholders to act by written consent without a meeting were as follows:
Votes For
(% of voted shares and % of outstanding shares)
Votes Against
(% of voted shares and % of outstanding shares)
Abstentions
(% of outstanding shares)
Broker
Non-Votes
(% of outstanding shares)
48,925,111
(47.65% and 36.00%)
53,751,626
(52.35% and 39.55%)
489,298
(0.37%)
12,370,096
(9.10%)

Accordingly, a majority of votes cast on this stockholder proposal were not in favor of the advisory proposal and the proposal was not adopted.

Item 9.01 (d) Exhibits

The following exhibits are filed pursuant to Item 9.01(d):

104  Cover Page Interactive Data File




 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
  
Eastman Chemical Company 
 
 By:/s/ Brian L. Henry
Brian L. Henry
Senior Securities-Governance Counsel and Assistant Secretary
  Date: May 13, 2020